Neoplastic Cells, Circulating
"Neoplastic Cells, Circulating" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors.
| Descriptor ID |
D009360
|
| MeSH Number(s) |
A11.642 C04.697.650.900 C23.550.727.650.900
|
| Concept/Terms |
Neoplastic Cells, Circulating- Neoplastic Cells, Circulating
- Circulating Cells, Neoplasm
- Neoplasm Circulating Cells
- Circulating Tumor Cells
- Cell, Circulating Tumor
- Cells, Circulating Tumor
- Circulating Tumor Cell
- Tumor Cell, Circulating
- Tumor Cells, Circulating
- Cells, Neoplasm Circulating
- Cell, Neoplasm Circulating
- Neoplasm Circulating Cell
- Circulating Neoplastic Cells
- Cell, Circulating Neoplastic
- Cells, Circulating Neoplastic
- Circulating Neoplastic Cell
- Neoplastic Cell, Circulating
Tumor Cells, Embolic- Tumor Cells, Embolic
- Cell, Embolic Tumor
- Cells, Embolic Tumor
- Embolic Tumor Cell
- Tumor Cell, Embolic
- Embolic Tumor Cells
Embolism, Tumor- Embolism, Tumor
- Embolisms, Tumor
- Tumor Embolism
- Tumor Embolisms
|
Below are MeSH descriptors whose meaning is more general than "Neoplastic Cells, Circulating".
Below are MeSH descriptors whose meaning is more specific than "Neoplastic Cells, Circulating".
This graph shows the total number of publications written about "Neoplastic Cells, Circulating" by people in this website by year, and whether "Neoplastic Cells, Circulating" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 1 | 3 |
| 2004 | 0 | 1 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 3 | 4 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 3 | 4 |
| 2015 | 2 | 2 | 4 |
| 2016 | 0 | 2 | 2 |
| 2017 | 3 | 0 | 3 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 2 | 3 |
| 2020 | 4 | 2 | 6 |
| 2021 | 3 | 1 | 4 |
| 2023 | 2 | 0 | 2 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplastic Cells, Circulating" by people in Profiles.
-
Clinical Utility of a Circulating Tumor Cell-Based Cerebrospinal Fluid Assay in the Diagnosis and Molecular Analysis of Leptomeningeal Disease in Patients With Advanced Non-Small Cell Lung Cancer. JCO Precis Oncol. 2024 Dec; 8:e2400373.
-
The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide. Clin Cancer Res. 2024 Mar 15; 30(6):1152-1159.
-
The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring. Cell Rep Med. 2023 10 17; 4(10):101198.
-
PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate Cancer. Clin Cancer Res. 2023 05 15; 29(10):1929-1937.
-
Application of liquid biopsy as multi-functional biomarkers in head and neck cancer. Br J Cancer. 2022 02; 126(3):361-370.
-
Early Diagnosis and Screening for Lung Cancer. Cold Spring Harb Perspect Med. 2021 09 01; 11(9).
-
Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer. Eur J Cancer. 2021 06; 150:83-94.
-
Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide. Clin Cancer Res. 2021 07 15; 27(14):4077-4088.
-
Endoscopic ultrasound acquired portal venous circulating tumor cells predict progression free survival and overall survival in patients with pancreaticobiliary cancers. Pancreatology. 2020 Dec; 20(8):1747-1754.
-
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors. J Clin Oncol. 2020 11 01; 38(31):3672-3684.